Vytorin
Product Images NDC 54868-5259

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vytorin (NDC 54868-5259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Bottle Label 10/20)

VYTORIN 10/20 MG tablet bottle label from Physicians Total Care, Inc. The label displays the product name, active ingredients (Ezetimibe/Simvastatin), strength, quantity of 30 tablets, dosing instructions, lot number, and expiration date. It includes regulatory caution statements and storage recommendations.*

FDA Label Image

Principal Display Panel (Bottle Label 10/40)

VYTORIN 10/40 MG tablet bottle label by Physicians Total Care, Inc., containing 30 tablets. The label includes dosage information, federal caution against dispensing without prescription, NDC number 54868-5189-1, barcodes, lot and expiration details, and instructions to refer to accompanying literature for use.*

FDA Label Image

Principal Display Panel (Bottle Label 10/10)

VYTORIN 10/10MG tablet packaging label from Physicians Total Care, Inc. displays the proprietary name, strength (10/10 mg), lot number 0000, expiration date 01/58, and barcode with the NDC 52580-5250-8. The label indicates a count of 30 tablets per package.*

FDA Label Image

Principal Display Panel (Bottle Label 10/80)

Packaged label for VYTORIN 10/80 mg tablets, containing 30 tablets. The label identifies Physicians Total Care, Inc. as the labeler and includes the active ingredients ezetimibe and simvastatin. The label also shows the NDC number 54868-5259-1, a lot number 82039, and an expiration date of 05/00. It features a caution statement about federal law prohibiting dispensing without a prescription.*

FDA Label Image

Image Of Ezetimibe Structural Formula (Vytorin 01)

Chemical structure of the active ingredient shown for VYTORIN, a drug labeler by Physicians Total Care, Inc. The structure depicts a complex molecule including aromatic rings, fluorine atoms, hydroxyl groups, and a beta-lactam ring system.*

FDA Label Image

Image Of Simvastatin Structural Formula (Vytorin 02)

Chemical structure diagram of the active ingredient for VYTORIN, showing the detailed molecular formula. The structure displays multiple ring systems, functional groups including hydroxyl and ketone groups, and stereochemical bonds, representing the compound's 3D configuration.*

FDA Label Image

Image Of Figure 1 (Vytorin 03)

A line graph titled 'Major Vascular Events' comparing the percentage of patients with events over 5 years of follow-up between Placebo (Pbo) and VYTORIN (VYT). The graph shows cumulative patient events increasing over time, with VYTORIN having fewer events than Placebo. A log-rank test indicates a P-value of 0.001. Patient counts at risk for each group are presented below the x-axis for each year.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.